ABSTRACT
Fifty-four patients with acute myeloid leukemia [AML] were included in this study and followed up from October, 1989 till April, 1992. Their median age was 35 years with female to male ratio of 1.4 :1. There was high incidence of M3 [24%]. Tweleve patients didn't receive chemotherapy. Other received either low-dose cytarabine [Cytosar] [18 patiens] or combination chemotherapy containing either daunorubicine [14 patients] or mitoxontrone [10 patients]. In the treated patients the rate of complete remission was 35.7%. The rate of early death was 23.8%. In all treated patients the median survival was 22 weeks. In conclusion, AML is more common in females than males. The commonest FAB - subtype is M2. There is a high incidence of Ms. The complete rate is lower than that reported m the western countries